Literature DB >> 23419814

The transdermal delivery of fentanyl.

Majella E Lane1.   

Abstract

The fentanyl patch is one of the great commercial successes in transdermal drug delivery. The suitability of this molecule for delivery through skin had been identified in the 1970s, and subsequently, a number of transdermal formulations became available on the market. This article reviews the development of fentanyl patch technology with particular emphasis on the pharmacokinetics and disposition of the drug when delivered through the skin. The various patch designs are considered as well as the bioequivalence of the different designs. The influence of heat on fentanyl permeation is highlighted. Post-mortem redistribution of fentanyl is discussed in light of the reported discrepancies in serum levels reported in patients after death compared with therapeutic levels in living subjects. Finally, alternatives to patch technology are considered, and recent novel transdermal formulations are highlighted.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23419814     DOI: 10.1016/j.ejpb.2013.01.018

Source DB:  PubMed          Journal:  Eur J Pharm Biopharm        ISSN: 0939-6411            Impact factor:   5.571


  10 in total

Review 1.  Options for Treating Pain in Cancer Patients with Dysphagia.

Authors:  Sebastiano Mercadante
Journal:  Drugs       Date:  2017-04       Impact factor: 9.546

Review 2.  Fentanyl Iontophoretic Transdermal System: A Review in Acute Postoperative Pain.

Authors:  Lesley J Scott
Journal:  Clin Drug Investig       Date:  2016-04       Impact factor: 2.859

3.  Pharmacokinetics of a Transdermal Fentanyl Solution in Suffolk Sheep (Ovis aries).

Authors:  Kimberly Y Jen; Melissa C Dyson; Patrick A Lester; Jean A Nemzek
Journal:  J Am Assoc Lab Anim Sci       Date:  2017-09-01       Impact factor: 1.232

4.  A case of overdose via tattoo.

Authors:  Roberta Borg; Antony Ashton
Journal:  J Intensive Care Soc       Date:  2015-02-23

5.  Safety of fentanyl initiation according to past opioid exposure among patients newly prescribed fentanyl patches.

Authors:  Kevin J Friesen; Cornelius Woelk; Shawn Bugden
Journal:  CMAJ       Date:  2016-04-04       Impact factor: 8.262

6.  Poor adhesion of fentanyl transdermal patches may mimic end-of-dosage failure after 48 hours and prompt early patch replacement in hospitalized cancer pain patients.

Authors:  Isabelle Arnet; Sabrina Schacher; Eva Balmer; Dieter Koeberle; Kurt E Hersberger
Journal:  J Pain Res       Date:  2016-11-09       Impact factor: 3.133

Review 7.  Transmucosal drug administration as an alternative route in palliative and end-of-life care during the COVID-19 pandemic.

Authors:  Jenny K W Lam; Chucky C K Cheung; Michael Y T Chow; Emily Harrop; Susie Lapwood; Stephen I G Barclay; Ian C K Wong
Journal:  Adv Drug Deliv Rev       Date:  2020-11-01       Impact factor: 15.470

Review 8.  Pain Therapy Guided by Purpose and Perspective in Light of the Opioid Epidemic.

Authors:  Amie L Severino; Arash Shadfar; Joshua K Hakimian; Oliver Crane; Ganeev Singh; Keith Heinzerling; Wendy M Walwyn
Journal:  Front Psychiatry       Date:  2018-04-23       Impact factor: 4.157

9.  Safety, Tolerability, and Dose Proportionality of a Novel Transdermal Fentanyl Matrix Patch and Bioequivalence With a Matrix Fentanyl Patch: Two Phase 1 Single-Center Open-Label, Randomized Crossover Studies in Healthy Japanese Volunteers.

Authors:  Ulrike Lorch; Tomasz Pierscionek; Anne Freier; Christopher S Spencer; Jörg Täubel
Journal:  Clin Pharmacol Drug Dev       Date:  2020-08-03

10.  Monitoring the Effect of Transdermal Drug Delivery Patches on the Skin Using Terahertz Sensing.

Authors:  Hannah Lindley-Hatcher; Jiarui Wang; Arturo I Hernandez-Serrano; Joseph Hardwicke; Gabit Nurumbetov; David M Haddleton; Emma Pickwell-MacPherson
Journal:  Pharmaceutics       Date:  2021-12-01       Impact factor: 6.321

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.